• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 特斯拉和 7 特斯拉下细胞和小鼠的 MRI 与 Gd 靶向剂:低场更好!

MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: when the low field is better!

机构信息

Department of Chemistry IFM, Center for Molecular Imaging, University of Torino, Torino, Italy.

出版信息

Contrast Media Mol Imaging. 2011 Nov-Dec;6(6):421-5. doi: 10.1002/cmmi.436.

DOI:10.1002/cmmi.436
PMID:22144019
Abstract

Tumor cells were targeted with Gd-loaded/LDL (low density lipoproteins) adducts consisting of ca 300 Gd(III) amphiphilic complexes incorporated in the lipophilic LDL particles. The long reorientational time of the Gd(III) complex in the supramolecular adduct yielded a relaxivity peak at ca 1 T, whereas its relaxivity at 7 T was 5 times less. The field-dependent relaxivity markedly affected the signal enhancement attainable at the two magnetic fields. As tumor cells showed up-regulation of LDL transporters, B16 melanoma cells were labeled with the Gd-loaded/LDL adduct. Each cell contained ca 2 × 10(9) Gd atoms. Upon dispersion of 5000 labeled cells in 1 μl of agar, signal intensity (SI) enhancements of about 30 and 7% were observed at 1 and 7 T, respectively. The results obtained on cellular systems were confirmed in vivo upon the administration of Gd-loaded/LDL particles to C57 mice bearing a transplanted melanoma (B16) tumor. From the herein reported results, one may conclude that, for slowly moving Gd complexes, it is possible to obtain in vivo sensitivity enhancements at 1 T several times higher than that attained at high fields.

摘要

肿瘤细胞被靶向的 Gd 负载/LDL(低密度脂蛋白)加合物,由约 300 个 Gd(III)两亲配合物掺入亲脂性 LDL 颗粒中组成。超分子加合物中 Gd(III)配合物的长重定向时间在约 1 T 处产生弛豫率峰值,而其在 7 T 处的弛豫率则降低了 5 倍。场依赖性弛豫率显著影响了在两种磁场下可获得的信号增强。由于肿瘤细胞显示 LDL 转运蛋白的上调,B16 黑色素瘤细胞用 Gd 负载/LDL 加合物进行标记。每个细胞含有约 2×10(9)个 Gd 原子。当将 5000 个标记细胞分散在 1 μl 琼脂中时,在 1 和 7 T 下,信号强度(SI)分别增强了约 30%和 7%。在携带移植黑色素瘤(B16)肿瘤的 C57 小鼠中给予 Gd 负载/LDL 颗粒后,在体内证实了在细胞系统上获得的结果。根据本文报道的结果,可以得出结论,对于缓慢移动的 Gd 配合物,在 1 T 下获得比在高场下更高的体内灵敏度增强是有可能的。

相似文献

1
MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: when the low field is better!1 特斯拉和 7 特斯拉下细胞和小鼠的 MRI 与 Gd 靶向剂:低场更好!
Contrast Media Mol Imaging. 2011 Nov-Dec;6(6):421-5. doi: 10.1002/cmmi.436.
2
Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles.通过用负载钆的低密度脂蛋白颗粒靶向低密度脂蛋白受体进行磁共振成像检测肿瘤细胞。
Neoplasia. 2007 Dec;9(12):1046-56. doi: 10.1593/neo.07682.
3
Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T).新型聚[N,N-双(3-氨丙基)甘氨酸](PAPGly)树状大分子钆基造影剂的合成及弛豫性能表征及其在低场(1 T)下利用动态对比增强 MRI 技术的体内研究。
Chem Biodivers. 2019 Nov;16(11):e1900322. doi: 10.1002/cbdv.201900322. Epub 2019 Oct 29.
4
LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.载脂蛋白 B 介导的紫杉醇和磁共振成像探针传递用于个体化医疗应用。
J Nanobiotechnology. 2021 Jul 13;19(1):208. doi: 10.1186/s12951-021-00955-9.
5
In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.用一种巯基反应性的基于钆的 MRI 对比剂对 B16 黑色素瘤肿瘤异种移植物进行体内标记。
Mol Pharm. 2011 Oct 3;8(5):1750-6. doi: 10.1021/mp2001044. Epub 2011 Aug 5.
6
Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.载钆壳聚糖纳米颗粒作为磁共振成像对比剂用于肿瘤的诊断。
J Biomed Nanotechnol. 2013 May;9(5):863-9. doi: 10.1166/jbn.2013.1584.
7
MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.MRI 引导的中子俘获治疗,使用双重镥/硼试剂,通过上调的低密度脂蛋白转运蛋白靶向肿瘤细胞。
Chemistry. 2011 Jul 18;17(30):8479-86. doi: 10.1002/chem.201003741. Epub 2011 Jun 10.
8
First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.首次对具有显著高场弛豫率的自组装金属星状化合物进行体内磁共振成像评估。
Contrast Media Mol Imaging. 2006 Jan-Feb;1(1):30-9. doi: 10.1002/cmmi.92.
9
Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.聚二硫醚钆(III)配合物作为可生物降解的大分子磁共振成像造影剂时,其结构对降解性及体内造影增强的影响
Magn Reson Imaging. 2009 May;27(4):503-11. doi: 10.1016/j.mri.2008.07.020. Epub 2008 Sep 23.
10
Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.作为磁共振成像造影剂的低密度脂蛋白纳米颗粒。
Neoplasia. 2006 Jun;8(6):488-98. doi: 10.1593/neo.05835.

引用本文的文献

1
Dynamic Contrast Enhanced (DCE) MRI-Derived Renal Perfusion and Filtration: Experimental Protocol.动态对比增强(DCE)MRI 衍生的肾脏灌注和滤过:实验方案。
Methods Mol Biol. 2021;2216:429-441. doi: 10.1007/978-1-0716-0978-1_25.
2
Low-field MRI: An MR physics perspective.低场 MRI:磁共振物理视角。
J Magn Reson Imaging. 2019 Jun;49(6):1528-1542. doi: 10.1002/jmri.26637. Epub 2019 Jan 13.
3
Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting.胰腺癌诱导性消耗的慢进展模型中的代谢改变。
Oxid Med Cell Longev. 2018 Feb 26;2018:6419805. doi: 10.1155/2018/6419805. eCollection 2018.
4
The RNA-binding protein ESRP1 promotes human colorectal cancer progression.RNA结合蛋白ESRP1促进人类结直肠癌进展。
Oncotarget. 2017 Feb 7;8(6):10007-10024. doi: 10.18632/oncotarget.14318.
5
Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging.通过动态对比增强磁共振成像评估肿瘤血管生成作为胃肠道间质瘤中伊马替尼耐药性的潜在生物标志物。
Gastric Cancer. 2017 Jul;20(4):629-639. doi: 10.1007/s10120-016-0672-7. Epub 2016 Dec 19.
6
Caspase-responsive smart gadolinium-based contrast agent for magnetic resonance imaging of drug-induced apoptosis.用于药物诱导细胞凋亡磁共振成像的半胱天冬酶响应型智能钆基造影剂
Chem Sci. 2014 Oct 1;4(10):3845-3852. doi: 10.1039/C4SC01392A.
7
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors.一种针对血管生成素的疫苗会引起抗体反应,改变肿瘤血管的通透性,并阻碍已建立的肿瘤的生长。
Angiogenesis. 2012 Jun;15(2):305-16. doi: 10.1007/s10456-012-9263-3. Epub 2012 Mar 17.